Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027

Abstract
The infection surveillance solutions market is anticipated to grow from an estimated USD 577 million in 2022 to USD 1,100 million in 2027, at a CAGR of 13.8% during the forecast period. The market has a promising growth potential due to increased demand the increasing prevalence of hospital-acquired infections, increasing surgical procedures, and rising healthcare expenditure among other factors. However, the Shortage of skilled healthcare IT professionals and Data security concerns are expected to limit the growth of this market to a certain extent.

“Training & Consulting Services: The fastest-growing segment of the infection surveillance services market, by type“

Training & consulting services are expected to witness the fastest growth in the infection surveillance services market during the forecast. Training and consulting services increase healthcare providers’ awareness of the latest infection surveillance solutions available in the market. Most large and mid-size companies actively provide technical assistance to hospitals, independent laboratories, and physician office laboratories that use infection surveillance software. Factors such as the increasing importance of value-based care, technological advancements, and growing consolidation in healthcare are driving the market for consulting services.

“The large hospitals is anticipated to be the largest infection surveillance solutions market for hospitals, by type, during the forecast period”

Based on type (the number of beds), hospitals are segmented into large (>450 beds), medium-sized (250–449 beds), and small (

“Europe accounted for the second-largest share in the infection surveillance solutions market during the forecast period”

Europe accounted for the second-largest share of the infection surveillance solutions market during the forecast period. Growth in the European market can be attributed to the increasing adoption of HCIT solutions, the increasing incidence of HAIs, the increasing number of surgeries, and the rising geriatric population. The increasing need to improve patient outcomes has contributed to the adoption of infection surveillance solutions across the region. Several policies and guidelines have been implemented in Europe as infection prevention strategies for hospitals and long-term care facilities which are propelling the demand for infection surveillance solutions in the region.

Break of primary participants was as mentioned below:
•By Company Type – Tier 1–40%, Tier 2–35%, and Tier 3–25%
•By Designation – C-level–35%, Director-level–25%, Others–40%
•By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the Infection Surveillance Solutions Market
The key players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US).

Research Coverage:
The report analyzes the infection surveillance solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service, end user, and region. The report also includes a product portfolio matrix of various infection surveillance solutions products & services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection surveillance solutions market. The report analyzes this market by product & service and end user.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection surveillance solutions market
•Market Development: Comprehensive information on the lucrative emerging markets by products & services and end user
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global infection surveillance solutions market
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global infection surveillance solutions market.

Content
Table of Contents

1INTRODUCTION34
1.1STUDY OBJECTIVES34
1.2MARKET DEFINITION34
1.2.1INCLUSIONS AND EXCLUSIONS35
1.3MARKET SEGMENTATION35
FIGURE 1INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION35
1.4YEARS CONSIDERED36
1.5CURRENCY CONSIDERED36
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD36
1.6STAKEHOLDERS37
1.7SUMMARY OF CHANGES37
1.8RECESSION IMPACT38
2RESEARCH METHODOLOGY39
2.1RESEARCH APPROACH39
FIGURE 2INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN40
2.2RESEARCH METHODOLOGY DESIGN41
2.2.1SECONDARY RESEARCH42
2.2.1.1Key data from secondary sources43
2.2.2PRIMARY DATA43
FIGURE 3PRIMARY SOURCES44
2.2.2.1Key data from primary sources45
2.2.2.2Key insights from primary experts46
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS46
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION47
2.3MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET47
FIGURE 6MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS48
FIGURE 7REVENUE SHARE ANALYSIS ILLUSTRATION49
FIGURE 8CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES51
FIGURE 9CAGR PROJECTIONS52
FIGURE 10TOP-DOWN APPROACH52
2.4DATA TRIANGULATION APPROACH54
FIGURE 11DATA TRIANGULATION METHODOLOGY54
2.5MARKET SHARE ESTIMATION55
2.6ASSUMPTIONS FOR THE STUDY55
 
2.7LIMITATIONS56
2.7.1METHODOLOGY-RELATED LIMITATIONS56
2.7.2SCOPE-RELATED LIMITATIONS56
2.8RISK ASSESSMENT56
TABLE 2RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET56
3EXECUTIVE SUMMARY57
FIGURE 12INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)57
FIGURE 13INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)58
FIGURE 14INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)58
FIGURE 15INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)59
FIGURE 16INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT, 202160
4PREMIUM INSIGHTS61
4.1INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW61
FIGURE 17GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH61
4.2NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY END USER AND COUNTRY62
FIGURE 18HOSPITALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 202162
4.3INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES63
FIGURE 19CHINA TO REGISTER HIGHEST REVENUE GROWTH FROM 2022 TO 202763
4.4INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2020–2027)64
FIGURE 20NORTH AMERICA TO DOMINATE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING FORECAST PERIOD64
4.5INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS64
FIGURE 21DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD64
5MARKET OVERVIEW65
5.1INTRODUCTION65
5.2MARKET DYNAMICS65
TABLE 3MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET65
5.2.1MARKET DRIVERS66
5.2.1.1Increasing prevalence of hospital-acquired infections66
5.2.1.2Increasing adoption of antimicrobial stewardship programs67
5.2.1.3Increasing number of surgeries67
TABLE 4US: PERCENTAGE INCREASE IN SURGICAL VOLUMES67
5.2.1.4Growing geriatric population and increasing incidence of chronic diseases68
5.2.1.5Growing investments to improve healthcare systems69
5.2.2MARKET RESTRAINTS69
5.2.2.1High cost of deployment for small healthcare organizations69
TABLE 5AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 202170
5.2.2.2Reluctance among medical professionals to adopt advanced healthcare IT solutions70
5.2.3MARKET OPPORTUNITIES71
5.2.3.1Increasing consolidation in healthcare industry71
5.2.3.2Cloud-based software solutions71
5.2.3.3Emerging markets71
5.2.4MARKET CHALLENGES72
5.2.4.1Shortage of skilled healthcare IT professionals72
5.2.4.2Data security concerns72
6INDUSTRY TRENDS73
6.1INTRODUCTION73
6.2INDUSTRY TRENDS73
6.2.1SHIFT TOWARD WEB-BASED SOLUTIONS73
6.2.2AI-POWERED SURVEILLANCE SOFTWARE73
6.2.3SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES74
6.2.4INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS74
6.3REGULATORY ANALYSIS74
6.3.1NORTH AMERICA74
TABLE 6NORTH AMERICA: REGULATIONS AND LAWS75
6.3.2EUROPE76
TABLE 7EUROPE: REGULATIONS AND LAWS76
6.3.3ASIA77
TABLE 8ASIA: REGULATIONS AND LAWS77
6.3.4MIDDLE EAST & AFRICA78
TABLE 9MIDDLE EAST & AFRICA: REGULATIONS AND LAWS78
6.3.5LATIN AMERICA78
TABLE 10LATIN AMERICA: REGULATIONS AND LAWS78
TABLE 11KEY GLOBAL REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS79
6.4TECHNOLOGY ANALYSIS80
6.4.1CLOUD COMPUTING TECHNOLOGY80
6.4.2ARTIFICIAL INTELLIGENCE80
TABLE 12AI IN HEALTHCARE MARKET, BY REGION, 2017–2020 (USD MILLION)80
TABLE 13AI IN HEALTHCARE MARKET, BY REGION, 2021–2027 (USD MILLION)81
6.4.3BLUETOOTH LOW-ENERGY SENSORS81
6.5ECOSYSTEM ANALYSIS81
FIGURE 22HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS81
FIGURE 23INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS82
6.6PATENT ANALYSIS82
6.6.1PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS82
FIGURE 24PATENT PUBLICATION TRENDS (JANUARY 2012–JANUARY 2023)83
6.6.2JURISDICTION AND TOP APPLICANT ANALYSIS83
FIGURE 25TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012– JANUARY 2023)84
FIGURE 26TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012–JANUARY 2023)85
TABLE 14INFECTION SURVEILLANCE SOLUTIONS: LIST OF PATENTS/PATENT APPLICATIONS, 2020–202285
6.7IMPACT OF RECESSION88
7INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE89
7.1INTRODUCTION90
TABLE 15INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)90
7.2SOFTWARE90
TABLE 16INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)91
TABLE 17INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)92
7.2.1ON-PREMISE SOFTWARE93
7.2.1.1Data protection and in-house access to HCIT solutions to drive market93
TABLE 18ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS93
TABLE 19ON-PREMISE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)94
7.2.2WEB-BASED SOFTWARE95
7.2.2.1Increasing demand for data centralization and cost-benefits of solutions to drive adoption95
TABLE 20WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS95
TABLE 21WEB-BASED SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)96
7.3SERVICES97
TABLE 22INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)97
TABLE 23INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)98
7.3.1PRODUCT SUPPORT & MAINTENANCE SERVICES98
7.3.1.1Rising reliance on outsourcing HCIT support to boost demand98
TABLE 24PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)99
7.3.2TRAINING & CONSULTING SERVICES100
7.3.2.1Need to develop IT infrastructure and demand for expert assistance to offer growth opportunities100
TABLE 25TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)100
7.3.3IMPLEMENTATION SERVICES101
7.3.3.1Focus on ensuring regulatory compliance among end users to boost service sector growth101
TABLE 26IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)101
8INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER102
8.1INTRODUCTION103
TABLE 27INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)103
8.2HOSPITALS103
TABLE 28INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)104
TABLE 29INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)104
8.2.1LARGE HOSPITALS105
8.2.1.1Growing need to deploy cloud-based solutions to drive growth105
TABLE 30INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)105
8.2.2MEDIUM-SIZED HOSPITALS106
8.2.2.1Increasing demand for more specialized and advanced care to boost market106
TABLE 31INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)106
8.2.3SMALL HOSPITALS107
8.2.3.1Need to decrease operational costs and growing competition to support adoption107
TABLE 32INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)107
8.3LONG-TERM CARE FACILITIES108
TABLE 33INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 34INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)109
8.3.1NURSING HOMES109
8.3.1.1Growing geriatric population to favor end-user growth109
TABLE 35INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES, BY COUNTRY, 2020–2027 (USD MILLION)110
8.3.2SKILLED NURSING FACILITIES110
8.3.2.1Advancements in HCIT solutions to favor adoption in SNFs110
TABLE 36INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)111
8.3.3ASSISTED LIVING FACILITIES111
8.3.3.1ALFs to show significant growth alongside rising geriatric population111
TABLE 37INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)112
8.4OTHER END USERS112
TABLE 38INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)113
9INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION114
9.1INTRODUCTION115
FIGURE 27INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2020–2027)115
TABLE 39INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)116
9.2NORTH AMERICA116
9.2.1NORTH AMERICA: IMPACT OF ECONOMIC RECESSION117
FIGURE 28NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT117
TABLE 40NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 41NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)118
TABLE 42NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)118
TABLE 43NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 44NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)119
TABLE 45NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 46NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)120
9.2.2US120
9.2.2.1Advanced medical infrastructure and increasing healthcare expenditure to drive market growth120
TABLE 47US: KEY MACROINDICATORS121
TABLE 48US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)121
TABLE 49US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 50US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)122
TABLE 51US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)122
TABLE 52US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)122
TABLE 53US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)123
9.2.3CANADA123
9.2.3.1Rising adoption of advanced HCIT solutions to propel market growth123
TABLE 54CANADA: KEY MACROINDICATORS124
TABLE 55CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)125
TABLE 56CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 57CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 58CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)126
TABLE 59CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)126
TABLE 60CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)126
9.3EUROPE127
9.3.1EUROPE: IMPACT OF ECONOMIC RECESSION127
TABLE 61EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)128
TABLE 62EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)128
TABLE 63EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)128
TABLE 64EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)129
TABLE 65EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)129
TABLE 66EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)129
TABLE 67EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)130
9.3.2GERMANY130
9.3.2.1Germany to hold largest share of European market130
TABLE 68GERMANY: KEY MACROINDICATORS131
TABLE 69GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)131
TABLE 70GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 71GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 72GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)132
TABLE 73GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 74GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)133
9.3.3FRANCE133
9.3.3.1High healthcare spending and favorable government initiatives to drive market growth in France133
TABLE 75FRANCE: KEY MACROINDICATORS134
TABLE 76FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)134
TABLE 77FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 78FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 79FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)135
TABLE 80FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 81FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)136
9.3.4UK136
9.3.4.1Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK136
TABLE 82UK: KEY MACROINDICATORS137
TABLE 83UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)137
TABLE 84UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)137
TABLE 85UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 86UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)138
TABLE 87UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 88UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)139
9.3.5ITALY139
9.3.5.1Increasing adoption of eHealth technologies to propel market growth in Italy139
TABLE 89ITALY: KEY MACROINDICATORS140
TABLE 90ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)140
TABLE 91ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)140
TABLE 92ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)141
TABLE 93ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)141
TABLE 94ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)141
TABLE 95ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)142
9.3.6SPAIN142
9.3.6.1Emphasis on infrastructural improvement and rising disease prevalence to contribute to growth142
TABLE 96SPAIN: KEY MACROINDICATORS143
TABLE 97SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)143
TABLE 98SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 99SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 100SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)144
TABLE 101SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 102SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)145
9.3.7SWITZERLAND145
9.3.7.1Increasing demand for healthcare services and growing healthcare awareness to augment market145
TABLE 103SWITZERLAND: KEY MACROINDICATORS146
TABLE 104SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)146
TABLE 105SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 106SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 107SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)147
TABLE 108SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 109SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)148
9.3.8NETHERLANDS148
9.3.8.1Increasing healthcare initiatives to favor demand growth148
TABLE 110NETHERLANDS: KEY MACROINDICATORS149
TABLE 111NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)149
TABLE 112NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)149
TABLE 113NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)150
TABLE 114NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)150
TABLE 115NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)150
TABLE 116NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)151
9.3.9REST OF EUROPE151
TABLE 117ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)152
TABLE 118ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)152
TABLE 119ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)152
TABLE 120ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)153
TABLE 121ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)153
TABLE 122ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)153
9.4ASIA PACIFIC154
9.4.1ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION154
FIGURE 29ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT155
TABLE 123ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)156
TABLE 124ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)156
TABLE 125ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)156
TABLE 126ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)157
TABLE 127ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)157
TABLE 128ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)157
TABLE 129ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)158
9.4.2JAPAN158
9.4.2.1Japan to dominate APAC market over forecast period158
TABLE 130JAPAN: KEY MACROINDICATORS159
TABLE 131JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)159
TABLE 132JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)159
TABLE 133JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 134JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)160
TABLE 135JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 136JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)161
9.4.3CHINA161
9.4.3.1Healthcare infrastructure improvements in China to contribute to market growth161
TABLE 137CHINA: KEY MACROINDICATORS162
TABLE 138CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)162
TABLE 139CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 140CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 141CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)163
TABLE 142CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 143CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)164
9.4.4INDIA164
9.4.4.1Increasing demand for HCIT solutions to support market growth164
TABLE 144INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)165
TABLE 145INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)165
TABLE 146INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)166
TABLE 147INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)166
TABLE 148INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)166
TABLE 149INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)167
9.4.5AUSTRALIA AND NEW ZEALAND167
9.4.5.1Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ167
TABLE 150AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)168
TABLE 151AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)168
TABLE 152AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)169
TABLE 153AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)169
TABLE 154AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)169
TABLE 155AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)170
9.4.6SOUTH KOREA170
9.4.6.1Increasing medical tourism to boost market170
TABLE 156SOUTH KOREA: KEY MACROINDICATORS171
TABLE 157SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)171
TABLE 158SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 159SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 160SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)172
TABLE 161SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 162SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)173
9.4.7REST OF ASIA PACIFIC173
TABLE 163ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)174
TABLE 164ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)174
TABLE 165ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)174
TABLE 166ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)175
TABLE 167ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)175
TABLE 168ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)175
9.5LATIN AMERICA176
9.5.1FAVORABLE HCIT INITIATIVES TO DRIVE MARKET GROWTH176
9.5.2LATIN AMERICA: IMPACT OF ECONOMIC RECESSION177
TABLE 169LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)177
TABLE 170LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)177
TABLE 171LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 172LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)178
TABLE 173LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 174LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)179
9.6MIDDLE EAST & AFRICA179
9.6.1IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH179
9.6.2MIDDLE EAST AND AFRICA: IMPACT OF ECONOMIC RECESSION180
TABLE 175MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)180
TABLE 176MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)180
TABLE 177MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 178MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION)181
TABLE 179MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 180MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION)182
10COMPETITIVE LANDSCAPE183
10.1OVERVIEW183
10.2KEY PLAYER STRATEGIES183
10.2.1OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS184
10.3ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS186
10.4REVENUE SHARE ANALYSIS186
FIGURE 30REVENUE ANALYSIS OF KEY PLAYERS187
10.5MARKET SHARE ANALYSIS187
FIGURE 31INFECTION SURVEILLANCE SOLUTIONS MARKET: MARKET SHARE ANALYSIS, 2021188
10.6COMPETITIVE BENCHMARKING189
TABLE 181COMPANY FOOTPRINT ANALYSIS189
TABLE 182PRODUCT & SERVICE FOOTPRINT ANALYSIS (25 COMPANIES)190
TABLE 183END-USER FOOTPRINT ANALYSIS (25 COMPANIES)191
TABLE 184REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES)192
10.7COMPANY EVALUATION QUADRANT, 2021193
10.7.1STARS193
10.7.2PERVASIVE PLAYERS193
10.7.3EMERGING LEADERS193
10.7.4PARTICIPANTS193
FIGURE 32INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2021194
10.8COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021195
10.8.1PROGRESSIVE COMPANIES195
10.8.2DYNAMIC COMPANIES195
10.8.3RESPONSIVE COMPANIES195
10.8.4STARTING BLOCKS195
FIGURE 33INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021196
10.9COMPETITIVE SCENARIO197
10.9.1PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS197
TABLE 185INFECTION SURVEILLANCE SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS, 2020–2022197
10.9.2DEALS197
TABLE 186INFECTION SURVEILLANCE SOLUTIONS MARKET: DEALS, 2020–2022197
10.9.3OTHER DEVELOPMENTS199
TABLE 187INFECTION SURVEILLANCE SOLUTIONS MARKET: OTHER DEVELOPMENTS, 2020–2022199